A new type of hormonal treatment has been shown to extend life for men with advanced prostate cancer. The once-daily pill, known as MDV3100, is the first in a new class of medicines called androgen receptor signaling inhibitors (ARSI). The drug has been designed to bind to the receptors on prostate cancer cells that normally…
Membership Required
You must be a HM Subscriber to view this content.
Already have an account? Sign In
©2026 All rights reserved LaingBuisson
